Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-27

Clinical Trial Update: Effects of Pioglitazone on Stress Reactivity and Alcohol Craving [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating pioglitazone for stress reactivity and alcohol craving in individuals with Alcohol Use Disorder, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Alcohol Use Disorder | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-08-27